The SURECAN study (Survivors’ Rehabilitation Evaluation after Cancer) is a £2.7 million programme grant funded by the National Institute for Health Research (NIHR) which evaluates a new type of psychological therapy: acceptance and commitment therapy (ACT) plus work and/or physical activity intervention where appropriate called ACT+. Three million people are living with and beyond cancer which is set to increase to 5 million by 2040. One of the three people with a cancer diagnosis has a low quality life. ACT+ combined with a cultural humble approach to reflect the ethnic diversity of the UK, hopes to improve quality of life for people living with and beyond cancer. The sessions provide new insights on how this new therapy was developed, piloted and trialled within the NHS.